Abstract
In this study, we aimed to explore the expression levels of JAK2 and PTPRC in peripheral blood mononuclear cells (PBMCs) from SLE patients and controls, detect the effects of SLE activity on genes mRNA expression, and find the association between genes mRNA expression and clinical manifestations of patients. We performed quantitative real-time PCR (qRT-PCR) to test differences in the expression levels of JAK2 and PTPRC in PBMCs extracted from 135 patients with SLE and 130 healthy controls. Furthermore, we detected the regulatory effect of SNPs on gene expression by expression quantitative trait loci (eQTL). We also tested whether the genes mRNA expression was affected with the SLE activity and analyzed the relationship between genes mRNA expression and clinical manifestations of patients. The mRNA expression levels of JAK2 in SLE patients were significantly higher than those in healthy controls (P = 0.005), and PTPRC mRNA expression levels were significantly decreased (P < 0.001). However, no other statistical significance was detected. We found that the elevated JAK2 mRNA expression and the decreased PTPRC mRNA expression may play suggestive roles in the pathogenesis of SLE.
Key Points • The JAK2 mRNA expression levels in SLE patients were significantly higher than those in healthy controls. • The PTPRC mRNA expression levels in SLE were decreased. • JAK2 and PTPRC mRNA expression may play suggestive roles in the pathogenesis of SLE. |
Similar content being viewed by others
References
Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus 19(12):1365–1373. https://doi.org/10.1177/0961203310374305
Wang J, Yang S, Chen JJ, Zhou SM, He SM, Liang YH, Meng W, Yan XF, Liu JJ, Ye DQ, Zhang XJ (2006) Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res 298(10):485–491. https://doi.org/10.1007/s00403-006-0719-4
Deng Y, Tsao BP (2017) Updates in lupus genetics. Curr Rheumatol Rep 19(11):68. https://doi.org/10.1007/s11926-017-0695-z
Morris DL, Sheng Y, Zhang Y, Wang YF, Zhu Z, Tombleson P, Chen L, Cunninghame Graham DS, Bentham J, Roberts AL, Chen R, Zuo X, Wang T, Wen L, Yang C, Liu L, Yang L, Li F, Huang Y, Yin X, Yang S, Ronnblom L, Furnrohr BG, Voll RE, Schett G, Costedoat-Chalumeau N, Gaffney PM, Lau YL, Zhang X, Yang W, Cui Y, Vyse TJ (2016) Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat Genet 48(8):940–946. https://doi.org/10.1038/ng.3603
Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffiths E, Krawczyk C, Richardson CD, Aitken K, Iscove N, Koretzky G, Johnson P, Liu P, Rothstein DM, Penninger JM (2001) CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409(6818):349–354. https://doi.org/10.1038/35053086
Ghoreschi K, Laurence A, O’Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228(1):273–287. https://doi.org/10.1111/j.1600-065X.2008.00754.x
Li J, Zhao S, Yi M, Hu X, Xie H, Zhu W, Chen M (2011) Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36(2):109–115. https://doi.org/10.3969/j.issn.1672-7347.2011.02.003
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/1529-0131(199709)40:9<1725::aid-art29>3.0.co;2-y
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35(6):630–640
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262
Ohl K, Tenbrock K (2015) Regulatory T cells in systemic lupus erythematosus. Eur J Immunol 45(2):344–355. https://doi.org/10.1002/eji.201344280
Tsokos GC, Lo MS, Costa Reis P, Sullivan KE (2016) New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 12(12):716–730. https://doi.org/10.1038/nrrheum.2016.186
Konya C, Paz Z, Tsokos GC (2014) The role of T cells in systemic lupus erythematosus: an update. Curr Opin Rheumatol 26(5):493–501. https://doi.org/10.1097/bor.0000000000000082
Chiu S, Bharat A (2016) Role of monocytes and macrophages in regulating immune response following lung transplantation. Curr Opin Organ Transplant 21(3):239–245. https://doi.org/10.1097/mot.0000000000000313
Duhe RJ, Rui H, Greenwood JD, Garvey K, Farrar WL (1995) Cloning of the gene encoding rat JAK2, a protein tyrosine kinase. Gene 158(2):281–285
Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93(3):385–395
Cornez I, Yajnanarayana SP, Wolf AM, Wolf D (2017) JAK/STAT disruption induces immuno-deficiency: rationale for the development of JAK inhibitors as immunosuppressive drugs. Mol Cell Endocrinol 451:88–96. https://doi.org/10.1016/j.mce.2017.01.035
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100(5):2610–2615. https://doi.org/10.1073/pnas.0337679100
Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6):711–723. https://doi.org/10.1084/jem.20021553
Bauer JW, Baechler EC, Petri M, Batliwalla FM, Crawford D, Ortmann WA, Espe KJ, Li W, Patel DD, Gregersen PK, Behrens TW (2006) Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 3(12):e491. https://doi.org/10.1371/journal.pmed.0030491
Kawasaki M, Fujishiro M, Yamaguchi A, Nozawa K, Kaneko H, Takasaki Y, Takamori K, Ogawa H, Sekigawa I (2011) Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus 20(12):1231–1239. https://doi.org/10.1177/0961203311409963
Acknowledgments
We thank all the study participants and all the volunteers who have so willingly participated in this study, thus making this study possible.
Funding
This study was supported financially by the National Key Research and Development Program of China (2017YFC0909001 and 2016YFC0906102), the National Natural Science Foundation of China (81872527, 81803117, and 8132018016) and the Natural Science Foundation of Anhui Province (1808085QH284).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 22.1 kb)
Rights and permissions
About this article
Cite this article
Qian, D., Liu, L., Zhu, T. et al. JAK2 and PTPRC mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Rheumatol 39, 443–448 (2020). https://doi.org/10.1007/s10067-019-04778-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-019-04778-w